See also this year's filing and all EDGAR filings for this company.
PDF Report 0001034842_2023_RIGEL_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001034842, RIGEL PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 115,903,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 857,000 |
| 3 | remainder_Assets | 17,519,000 |
| 4 | LiabilitiesCurrent | 65,211,000 |
| 5 | LiabilitiesNoncurrent | 43,236,000 |
| 6 | remainder_Liabilities | 39,448,000 |
| 7 | CostOfGoodsAndServicesSold | 1,749,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 112,451,000 |
| 9 | ResearchAndDevelopmentExpense | 60,272,000 |
| 10 | remainder_Expenses | 5,027,000 |
| 11 | remainder_Revenues | 120,242,000 |
| 12 | remainder_NetIncome | 684,000 |
| 13 | remainder_ComprehensiveNetIncome | -51,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 134,279,000 |
| 1 | Liabilities | 147,895,000 |
| 2 | Expenses | 179,499,000 |
| 3 | Revenues | 120,242,000 |
| 4 | StockholdersEquity | -13,616,000 |
| 5 | NetIncome | -58,573,000 |
| 6 | ComprehensiveNetIncome | -58,598,500 |
| 7 | BaseVar | 291,325,000 |
| 8 | EconomicCapitalRatio | -0.581 |
Edgar->Model Mapping
Feature Distribution
Change over Time
